Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-15-018744
Filing Date
2015-09-30
Accepted
2015-09-30 18:11:00
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 4175
  Complete submission text file 0001225208-15-018744.txt   5802
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 151134832
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations